Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai
- 579 Downloads
Carbapenem-hydrolyzing β-lactamases are increasingly reported worldwide, leading to therapeutic failure. In an era where the drug development pipeline is stagnant, it is crucial to preserve current classes of antibiotics to help fight against infection caused by multidrug-resistant organisms (MDROs), by practicing a rational approach for the use of antibiotics. Identifying the mechanisms of resistance gives us much needed insights in this field. A total of 113 consecutive, non-duplicate carbapenem-resistant clinical isolates were collected from July to December 2012. These isolates were subjected to the modified Hodge test (MHT) for phenotypic detection of carbapenemases, an inhibitor-based test employing EDTA for the detection of metallo-β-lactamase (MBL), and phenylboronic acid for the detection of Klebsiella pneumoniae carbapenemase (KPC). A multiplex polymerase chain reaction (PCR) assay that characterized the five most predominant carbapenemases (bla NDM, bla OXA, bla VIM, bla IMP, bla KPC) was designed. The 113 isolates consisted of Klebsiella spp. (46), Enterobacter spp. (32), Escherichia coli (31), Citrobacter spp. (2), Proteus spp. (1), and Morganella spp. (1). bla NDM-1 was the most prevalent carbapenemase and accounted for 75.22 % (85/113) of the isolates. This was followed by bla OXA [4.42 % (n = 5)]. 18.5 % (21/113) of the isolates possessed dual carbapenemase genes. 98.9 % concordance was observed between the phenotypic tests and the molecular tests for the detection of MBL. In conclusion, patients infected with resistant bacteria require early appropriate antimicrobial treatment for good clinical outcome. Thus, identifying the resistant mechanisms of suspected pathogens becomes crucial. Also, the high incidence of plasmid-mediated bla NDM-1 calls for the implementation of strict infection control and contact isolation precautions in order to prevent the spread of these organisms.
KeywordsColistin Carbapenem Resistance Klebsiella Pneumoniae Carbapenemase Modify Hodge Test Strict Infection Control
Clinical and Laboratory Standards Institute
Combined disk test
We thank Dr. Anand Manoharan, Christian Medical College (CMC), Vellore for providing us with bla VIM- and bla IMP-positive controls, and Dr. Rajni Gaind, Consultant Microbiologist, Vardhman Mahavir Medical College (VMMC) and Associated Safdarjung Hospital, New Delhi for providing us with the bla KPC-positive control.
The project was funded by the National Health and Education Society.
Conflict of interest
None to declare.
- 5.Upadhyay S, Sen MR, Bhattacharjee A (2012) Identification and characterization of carbapenem hydrolysing β-lactamase—KPC among enterobacteriaceae: a report from North India. Asian J Med Sci 3:11–15Google Scholar
- 8.Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22Google Scholar
- 12.Lahey Clinic. Home page at: http://www.lahey.org/Studies
- 14.Nordmann P, Poirel L (2013) Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 68(3):487–489Google Scholar
- 17.Picão RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE et al (2008) Metallo-β-lactamase detection: comparative evaluation of double-disk synergy versus combined Disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 46(6):2028–2037CrossRefPubMedCentralPubMedGoogle Scholar
- 19.Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K et al (2009) Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054CrossRefPubMedCentralPubMedGoogle Scholar